Back to Journals » Clinical, Cosmetic and Investigational Dermatology » Volume 17

Short Report

Effectiveness and Safety of Tildrakizumab in Psoriasis Patients Who Failed Anti-IL17 Treatment: A 28-Week Real-Life Study

       
Total article views   HTML views PDF downloads Totals
899 Dovepress* 899+ 89 988
Totals 899 89 988
*Since 7 May 2024
Total mentioned Facebook Delicious Reddit Twitter Others
2 0 0 0 0 2

View citations on PubMed Central and Google Scholar